基于网络药理和分子对接探究山柰酚治疗抵抗性前列腺癌的机制
毛正， 谭武宾， 陈贵恒， 郑珏， 陈昊… - 实用中西医结合 …, 2022 - syzxyjhlc.cnjournals.org
… docking techniques, and to explore its related molecular … Conclusion: This study predicted
the core target, biological processes … in the treatment of castration-resistant prostate cancer. …
the core target, biological processes … in the treatment of castration-resistant prostate cancer. …
甲基轉移酶MTx 在前列腺癌細胞惡化以及對賀爾蒙療法產生抗性中所扮演的角色
CA Huang - 臺灣大學生物化學暨分子生物學研究所學位論文, 2019 - airitilibrary.com
… castration-resistant prostate cancer (CRPC) with poor prognosis and a high potential of
metastasis. The molecular … therapeutic target for drug development against advanced prostate …
metastasis. The molecular … therapeutic target for drug development against advanced prostate …
多西他赛耐药前列腺癌细胞系的差异基因筛选及功能分析
王明， 王磊， 张岩， 王超奇， 李爽， 樊涛 - Oncology and Translational …, 2022 - otm.tjh.com.cn
… for metastatic castration-resistant prostate cancer (PCa). … This study aimed to determine
key molecular genes in docetaxel-… genes may be potential targets for predicting and treating …
key molecular genes in docetaxel-… genes may be potential targets for predicting and treating …
甲基轉移酶在攝護腺癌惡化過程作用機制之研究
蔡心浩 - 2017 - airitilibrary.com
… The molecular mechanisms how PCa transforms to castration-resistant prostate cancer (CRPC) …
The results together indicate that MTH is involved in castration-resistant prostate cancer …
The results together indicate that MTH is involved in castration-resistant prostate cancer …
Molecular mechanism of spirit-quieting traditional Chinese medicine in the treatment of prostate cancer metastasis patients with depression: 宁神中药治疗前列腺癌 …
ZHU Liping, W Zhiqiang, LI Li, SU Zhiyong - 开元Medical-Research, 2022 - mrhk.cc
… treatment due to inherent or acquired resistance. Metastatic castration-resistant prostate
cancer is in … Therefore, targeted blockade of MAOA can effectively delay bone metastasis of …
cancer is in … Therefore, targeted blockade of MAOA can effectively delay bone metastasis of …
甲基轉移酶MTx 在前列腺癌細胞惡化以及對賀爾蒙療法產生抗性中所扮演的角色
黃晨銨 - 2019 - tdr.lib.ntu.edu.tw
… castration-resistant prostate cancer (CRPC) with poor prognosis and a high potential of
metastasis. The molecular … therapeutic target for drug development against advanced prostate …
metastasis. The molecular … therapeutic target for drug development against advanced prostate …
抗雄激素药物治疗去势抵抗型前列腺癌的机制研究进展
王前奔， 吴大勇 - 中国肿瘤临床, 2015 - cjco.cn
… 摘要去势抵抗型前列腺癌(castration-resistant prostate cancer,… to new agents targeting the
androgen axis[J]. Oncogene, … re⁃ current prostate cancer by a small-molecule inhibitor of the …
androgen axis[J]. Oncogene, … re⁃ current prostate cancer by a small-molecule inhibitor of the …
利用咖啡酸苯乙酯CAPE 作為LNCaP 104-R1 復發前列腺癌細胞株的治療藥物
PH Hsiao - 清華大學生物科技研究所學位論文, 2014 - airitilibrary.com
… prostate cancer (PCa). However, a majority of PCa patients receiving the androgen ablation
therapy will ultimately develop recurrent castration-resistant prostate cancer (… targets are …
therapy will ultimately develop recurrent castration-resistant prostate cancer (… targets are …
去势抵抗性前列腺癌的治疗进展
王晴， 杜君， 杨庆 - 中国肿瘤临床, 2016 - cjco.cn
… radionuclides, and bone-targeting drugs. These therapies can … treatment of castration-resistant
prostate cancer are briefly … Molecular features of hormone-refractory prostate cancer cells …
prostate cancer are briefly … Molecular features of hormone-refractory prostate cancer cells …
肿瘤翻译调控机制及其靶向药物的研究进展
郑慧敏， 徐易尘 - 中国现代应用药学, 2023 - zgxdyyyx.ijournals.cn
… -molecule inhibitor targeting the kinase of eIF4E, currently in phase II clinical trial for colorectal
and castration-resistant prostate cancers, … breast cancer and non-small cell lung cancer. …
and castration-resistant prostate cancers, … breast cancer and non-small cell lung cancer. …